Non-metastatic Castration-resistant Prostate Cancer
📧 Sign up to get email alerts when something new happens for Non-metastatic Castration-resistant Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment
An observational study in China assesses the efficacy and safety of darolutamide in combination with androgen deprivation therapy for men wi…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
This is an observational study in Korea assessing the safety of darolutamide in men with prostate cancer, including non-metastatic castratio…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) [Phase 4]
A Phase 4 clinical trial to assess safety and real-world effectiveness of adding darolutamide to standard androgen deprivation therapy in In…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: PROCARE - PROstate Cancer Real World Evidence Registry
PROCARE is a prostate cancer real-world evidence registry that is currently recruiting participants, collecting data across multiple disease…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer
Expanded Access Protocol update for apalutamide in non-metastatic castration-resistant prostate cancer; the protocol is no longer available.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: An Observational Cohort Study to Describe and Compare the Use of Darolutamide, Enzalutamide and Apalutamide and How Well These Work in Men With Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) in Real World Settings
This completed observational real-world study describes and compares the use and effectiveness of darolutamide, enzalutamide, and apalutamid…